Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion type Assertion NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_head.
- NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion description "[To determine whether this pathway of malignant transformation is important in prostate cancer, we analyzed 104 prostate cancer tissue specimens, 4 prostate cancer cell lines, and 3 prostate tumor xenografts for activating mutations in exon 3 of CTNNB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_provenance.
- NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion evidence source_evidence_literature NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_provenance.
- NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion SIO_000772 9635571 NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_provenance.
- NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion wasDerivedFrom befree-20140225 NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_provenance.
- NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_assertion wasGeneratedBy ECO_0000203 NP505001.RAGGUJAH0eeSl9A-FBuFDgSdxFI-U-o5aAmttHFZNMr9k130_provenance.